Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02237261
Brief Title: Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma (BPV)

First Submitted : June 9, 2014
First Submitted that Met QC Criteria : September 10, 2014
First Posted : September 11, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : May 12, 2018
Last Update Posted : May 15, 2018